Navigation Links
Immune cell discovery could help to halt cancer spread
Date:8/14/2014

Melbourne researchers have revealed the critical importance of highly specialised immune cells, called natural killer cells, in killing melanoma cells that have spread to the lungs.

These natural killer cells could be harnessed to hunt down and kill cancers that have spread in the body.

The team, from the Walter and Eliza Hall Institute, also found natural killer cells were critical to the body's rejection of donor bone marrow transplants and in the runaway immune response during toxic shock syndrome.

The discoveries came after the team showed that a protein called MCL-1 was crucial for survival of natural killer cells, in research published today in the journal Nature Communications. The discovery will help to determine how natural killer cells can be manipulated to fight cancers and other disorders.

Dr Nick Huntington, Dr Priyanka Sathe and Ms Rebecca Delconte from the Walter and Eliza Hall Institute said MCL-1 could be a target for boosting or depleting natural killer cell populations to treat disease. Natural killer cells are immune predators, scouring the body in search of foreign invaders such as viruses, and sensing changes in our own cells that are associated with cancer.

Dr Huntington said the team showed natural killer cells were needed to fight off invading tumour cells that had spread past the original cancer site.

"We discovered MCL-1 is absolutely essential for keeping natural killer cells alive," Dr Huntington said. "Without natural killer cells, the body was unable to destroy melanoma metastases that had spread throughout the body, and the cancers overwhelmed the lungs".

"Knowing how important natural killer cells are for detecting and destroying cancer cells as they spread suggests they would be a good target for boosting immune defenses to treat cancer."

Natural killer cells are present in high frequency in our blood and patrol the body's 'frontlines' the lungs, intestines, mucous membranes and skin to detect and destroy diseased cells. However these predatory natural killer cells are a double-edged sword.

Dr Huntington said the team showed natural killer cells also played a role in death from toxic shock (sepsis), and in rejecting bone marrow transplants.

"Natural killer cells led the response that caused rejection of donor stem cells in bone marrow transplantations," Dr Huntington said. "They also produced inflammatory signals that can result in toxic shock syndrome, a potentially fatal illness caused by bacterial toxins that causes a whole-body inflammatory reaction."

Dr Huntington said the discovery provided a solid lead to look for ways of boosting natural killer cells when they are needed in higher supply, or depleting them when they are causing illness.

"We showed MCL-1 levels inside the cell increase in response to a blood cell signalling protein called interleukin 15 (IL-15). We previously knew IL-15 boosted production and survival of natural killer cells, and we have shown that IL-15 does this by initiating a cascade of signals that tell the natural killer cell to produce MCL-1 to keep it alive."

"Now that we know the critical importance of MCL-1 in the survival of natural killer cells, we are investigating how we might manipulate this protein, or other proteins in the pathway, to treat disease," Dr Huntington said.


'/>"/>

Contact: Liz Williams
williams@wehi.edu.au
61-428-034-089
Walter and Eliza Hall Institute
Source:Eurekalert  

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
3. MU researchers identify key plant immune response in fight against bacteria
4. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
5. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
6. IGY Immune Technology & Life Sciences Purchases Manufacturing Facility to Produce Purified Immunoglobulin Y (IgY)
7. Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway
8. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
9. Genalyte Launches Maverick ENA Kits For Fast, Easy And Accurate Multiplexed Autoimmune Testing
10. AllCells Introduces Autoimmune Diseased Cells and Tissue Products
11. Novel Cancer Immune Therapy Developer Oncos Therapeutics Appoints Experienced Industry Leader Frans Wuite as President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Immune cell discovery could help to halt cancer spread
(Date:3/29/2017)... -- WuXi Biologics, a leading open-access R&D capability ... a WuXi AppTec Affiliate, today announced that it ... Award from IMAPAC, a leading consulting firm. ... outstanding leaders and trend-setters of today, and inspire ... experts in the industry, along with the latest ...
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, Inc. ... and drug-delivery therapies, today announced that an Oncologic ... Drug Administration voted 11 to 0 that the ... injection was favorable for patients in the proposed ... and chronic lymphocytic leukemia. The FDA action date ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... around 7.8% over the next decade to reach approximately $825.4 million ... estimates and forecasts for all the given segments on global as ...
(Date:3/29/2017)... The Global Microfluidic Chips Market by Manufacturers, ... and comprehensive study on the existing state of the global Microfluidic ... Europe and Asia-Pacific , ... and Africa . ... Browse 172 Tables and Figures, 13 Major Company ...
Breaking Biology Technology:
(Date:3/22/2017)... 2017   Neurotechnology , a provider of ... announced the release of the SentiVeillance 6.0 ... facial recognition using up to 10 surveillance, security ... The new version uses deep neural-network-based facial detection ... utilizes a Graphing Processing Unit (GPU) for enhanced ...
(Date:3/20/2017)... , March 20, 2017 PMD Healthcare announces ... spirometer and Wellness Management System (WMS), a remote, real-time ... in 2010, PMD Healthcare is a Medical Device, Digital ... mission dedicated to creating innovative solutions that empower people ... that intent focus, PMD developed the first ever personal ...
(Date:3/9/2017)... MOUNTAIN VIEW, Calif. , March 9, 2017 ... and 23andMe , the leading personal genetics company, ... Zipongo can now provide customers with personalized nutrition plans ... and biometrics, but also genetic markers impacting how their ... Zipongo,s personalized food decision support platform uses biometrics such ...
Breaking Biology News(10 mins):